[PHARMA] YoY Annualized Quarter Result on 30-Sep-2010 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
04-Nov-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Sep-2010 [#3]
Profit Trend
QoQ- -9.54%
YoY- -14.73%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 1,838,372 1,773,256 1,537,593 1,336,309 1,302,520 1,303,204 1,188,221 7.53%
PBT 79,986 132,088 75,757 64,217 71,930 88,137 72,434 1.66%
Tax -32,661 -37,856 -21,620 -21,201 -19,116 -30,154 -25,406 4.27%
NP 47,325 94,232 54,137 43,016 52,814 57,982 47,028 0.10%
-
NP to SH 45,849 92,860 53,620 43,520 51,038 56,322 45,348 0.18%
-
Tax Rate 40.83% 28.66% 28.54% 33.01% 26.58% 34.21% 35.07% -
Total Cost 1,791,046 1,679,024 1,483,456 1,293,293 1,249,705 1,245,221 1,141,193 7.79%
-
Net Worth 473,857 496,623 464,307 424,715 407,610 374,390 335,831 5.90%
Dividend
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Div 33,903 39,227 - 67,041 38,514 25,672 21,390 7.97%
Div Payout % 73.95% 42.24% - 154.05% 75.46% 45.58% 47.17% -
Equity
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Net Worth 473,857 496,623 464,307 424,715 407,610 374,390 335,831 5.90%
NOSH 258,938 117,683 106,983 106,981 106,984 106,968 106,952 15.86%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin 2.57% 5.31% 3.52% 3.22% 4.05% 4.45% 3.96% -
ROE 9.68% 18.70% 11.55% 10.25% 12.52% 15.04% 13.50% -
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
RPS 709.97 1,506.80 1,437.23 1,249.11 1,217.49 1,218.30 1,110.98 -7.18%
EPS 17.71 78.91 50.12 40.68 47.71 52.65 42.40 -13.52%
DPS 13.09 33.33 0.00 62.67 36.00 24.00 20.00 -6.81%
NAPS 1.83 4.22 4.34 3.97 3.81 3.50 3.14 -8.59%
Adjusted Per Share Value based on latest NOSH - 106,924
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
RPS 127.56 123.04 106.69 92.72 90.38 90.42 82.44 7.53%
EPS 3.18 6.44 3.72 3.02 3.54 3.91 3.15 0.15%
DPS 2.35 2.72 0.00 4.65 2.67 1.78 1.48 8.00%
NAPS 0.3288 0.3446 0.3222 0.2947 0.2828 0.2598 0.233 5.90%
Price Multiplier on Financial Quarter End Date
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Date 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 28/09/07 -
Price 4.82 7.55 5.90 4.98 4.09 3.24 3.27 -
P/RPS 0.68 0.50 0.41 0.40 0.34 0.27 0.29 15.24%
P/EPS 27.22 9.57 11.77 12.24 8.57 6.15 7.71 23.37%
EY 3.67 10.45 8.49 8.17 11.66 16.25 12.97 -18.95%
DY 2.72 4.42 0.00 12.58 8.80 7.41 6.12 -12.63%
P/NAPS 2.63 1.79 1.36 1.25 1.07 0.93 1.04 16.70%
Price Multiplier on Announcement Date
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Date 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 22/11/07 -
Price 4.72 8.25 5.90 4.92 3.93 3.35 3.42 -
P/RPS 0.66 0.55 0.41 0.39 0.32 0.27 0.31 13.40%
P/EPS 26.66 10.46 11.77 12.09 8.24 6.36 8.07 22.01%
EY 3.75 9.56 8.49 8.27 12.14 15.72 12.40 -18.05%
DY 2.77 4.04 0.00 12.74 9.16 7.16 5.85 -11.70%
P/NAPS 2.58 1.95 1.36 1.24 1.03 0.96 1.09 15.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment